title: Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY
abstract: ClinicalTrials.gov, NCT01061736 , February 2, 2010.
journal: Arthritis Research & Therapy